ASTRIA THERAPEUTICS INC (ATXS) Stock Balance Sheet
NASDAQ:ATXS • US04635X1028
12.58 USD
+0.08 (+0.64%)
At close: Jan 22, 2026
12.58 USD
0 (0%)
After Hours: 1/22/2026, 8:23:15 PM
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 48.62M | 29.21M | 167.82M | 18.60M | 84.70M | |||
| Cash Equivalents | 47.66M | 30.61M | 7.71M | 1.90M | 1.90M | |||
| Marketable Securities | 131.44M | 268.31M | 71.00M | 205.90M | 39.00M | |||
| Receivables | 17.24M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 8.58M | 6.51M | 4.41M | 1.30M | 1.50M | |||
| Total Current Assets | 253.55M | 334.64M | 250.94M | 227.70M | 127.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.25M | 5.11M | 363.00K | 900.00K | 400.00K | |||
| Other Non-Current Assets | 14.07M | 2.61M | 3.36M | 2.00M | 0.00 | |||
| Total Non-Current Assets | 18.32M | 7.72M | 3.72M | 2.90M | 400.00K | |||
| TOTAL ASSETS | 271.87M | 342.36M | 254.67M | 230.60M | 127.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 17.89M | 14.81M | 10.04M | 8.30M | 3.60M | |||
| Accounts Payable | 1.14M | 4.32M | 1.51M | 800.00K | 1.60M | |||
| Other Current Liabilities | 4.50M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 23.52M | 19.13M | 11.55M | 9.10M | 5.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 15.10M | 3.97M | 0.00 | 400.00K | 0.00 | |||
| Total Non-Current Liabilities | 15.10M | 3.97M | 0.00 | 300.00K | 0.00 | |||
| TOTAL LIABILITIES | 38.61M | 23.10M | 11.55M | 9.40M | 5.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -773.20M | -674.79M | -580.53M | -507.60M | -455.80M | |||
| Additional Paid In Capital | 911.01M | 898.51M | 728.28M | 632.50M | 481.70M | |||
| Common Shares | 95.38M | 95.38M | 95.36M | 96.40M | 96.40M | |||
| Other Shareholders' Equity | 56.00K | 163.00K | 0.00 | -100.00K | 0.00 | |||
| Shares Outstanding | 56.43M | 56.43M | 41.03M | 27.50M | 13.00M | |||
| Tangible Book Value per Share | 2.44 | 3.97 | 3.60 | 4.54 | 1.99 | |||
| Total Shareholders' Equity | 233.25M | 319.26M | 243.12M | 221.20M | 122.30M | |||
| TOTAL LIABILITIES AND EQUITY | 271.87M | 342.36M | 254.67M | 230.60M | 127.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.78 | 17.49 | 21.73 | 25.02 | 24.44 | |||
| Return On Assets (ROA) | -45.62% | -27.53% | -28.62% | -22.48% | -172.04% | |||
| Return On Equity (ROE) | -53.17% | -29.52% | -29.98% | -23.43% | -179.35% | |||
All data in USD , ROIC based on taxRate of 0.21